Juvenile xanthogranuloma (JXG) is a benign, non-Langerhans cell histiocytic proliferative disorder. We report a case of solitary JXG in an infant presenting as an intraspinal mass. Awareness of this mode of presentation is very important as subsequent prognosis differs from other tumors at the same location. JXG is a self-limiting dermatologic disorder usually occurring in first two decades of life. On rare occasion, it has been reported at extra-cutaneous sites such as central nervous system (CNS), eyes, liver, spleen, lungs and kidneys, and in other age groups. Isolated CNS involvement is extremely rare, especially in the spinal cord.
Introduction
Juvenile xanthogranuloma (JXG) is a benign, non-Langerhans histiocytic proliferative disorder of the skin which mainly occurs in childhood. It is rarely associated with systemic manifestation, and central nervous involvement is extremely rare. Etiology of JXG is not known. We report a case of solitary intraspinal JXG in an infant, presenting as paraplegia which is exceptional. An extensive literature search has revealed only two cases reported in this location in an infant. 
Case Report
The mother of a 1-year-old girl initially noticed reduced activity of the lower limbs which worsened over 8 days. On examination paraplegia, exaggerated deep tendon reflexes and positive Babinski sign were noted. No other neurological deficit found. Cutaneous lesions were absent. Magnetic resonance imaging (MRI) of the spine showed intradural extramedullary (IDEM) lesion at D6-D8 level suggestive of a benign nerve sheath tumor [ Figure 1 ].
Total excision of the tumor was done. Gross specimen included multiple bits yellowish-white, soft to firm. Histopathology showed tumor composed of sheets of spherical, ovoid, and spindle cells with vesicular bland nuclei. Many Touton giant cells were seen [ Figure 2 ].
On immunohistochemistry, the tumor cells were strongly positive for CD68 (histiocytic marker) and weakly for CD163 [ Figure 3 ]. Cells were negative for s100 protein, CD1a, glial fibrillary acidic protein, epithelial membrane antigen. Special stain such as Zeil Neelson, Gomori methenamine silver, and periodic acid-Schiff stain were negative, thus ruling out mycobacteria and fungi as etiologic agents. Thus, a diagnosis of JXG was made. The infant showed full clinical recovery. The patient was managed with regular follow-up only and is doing well until date.
Discussion
In the pediatric age group, dural intraspinal tumors account for about 50% of cases. They include neuroblastomas, Ewing's sarcomas, and more rarely, leukemia, lymphoma, rhabdomyosarcoma or as in our case -JXG.
JXG was first described in 1905 by Adamson as a "congenital xanthoma multiplex." [1] Histiocytic disorders are further subtyped as (1) dendritic-cell related, (2) macrophage-related, or (3) malignant histiocytic disorders. JXG is an example of a dendritic cell disorder, another being Langerhans cell histiocytosis (LCH). Macrophage-related disorders comprise Rosai-Dorfmann disease (RDD), and hemophagocyte lymphohistiocytosis and Erdheim Chester disease. [3] JXG in children are commonly seen at a median age of two years with a male:female system (CNS). The involvement of spine is extremely rare. [4, 5] Until date, only 14 cases have been described in English literature with solitary JXG of the spine.
[2, 4, [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] Table 1 summarizes the details of all the 14 cases. Six of these were in the cervical spine, 3 in the thoracic spine and 5 in the lumbosacral spine. JXG is a slow growing tumor and presents with features according to the location of the tumor. JXG are believed to be the result of altered macrophage response to a nonspecific injury, resulting in a granulomatous reaction. JXG was thought to be a reactive process; however, its clonal nature has recently been demonstrated, and leading credence to its neoplastic origin. [3] Spinal JXG presents clinically as an IDEM tumor, as an osteolytic lesion in the vertebral body, with spinal nerve root involvement, or a combination of all these features depending on the location of the tumor. [3] MRI is the best method for the localization of tumors and their relationship to adjacent structures. Spinal JXG may appear with variable signal intensity, i.e. a mixture of hypo-, iso-, and hyperintense in T1-weighted (T1W) and T2-weighted (T2W). Furthermore, the lesion may exhibit homogeneous enhancement after contrast media administration. In our case, the tumor showed isointense signal on T1WI and the hypointense signal on T2W with homogeneous contrast enhancement. [19] Upon gross anatomic examination, the JXG is a usually well-encapsulated yellowish-to-grayish mass with or without cystic components. Xanthogranuloma is confirmed through histopathological and immunohistochemical (IHC) studies. [6] Microscopically, there are foamy histiocytic cells with or without Touton giant cells, which can be found in a background of mononuclear cells, and spindle cells. Touton giant cells contain a ring of nuclei surrounding a central homogenous cytoplasm while foamy cytoplasm surrounds the nuclei. On IHC mononuclear cells, giant cells, and spindle cells are positive for the lysozyme stain and CD68 but negative for CD1a (excludes LCH) and S-100 proteins (excludes RDD), as seen in our case. [7, 8, 20] Currently, there is no standard treatment for solitary JXG involving the CNS because of extremely low incidence. Complete surgical resection of the tumor is curative. Recurrence has not been reported. However, the tumors involving the spine may grow slowly without regression and gradually worsens. This characteristic is significantly distinct from the skin lesions which show spontaneous regression. The patient should be followed up for long-term after total resection because the natural course of solitary CNS xanthogranuloma is unknown. [8] 
Conclusion
We report a very rare case of spinal JXG presenting as IDEM tumor. ratio of 1.5:1. The most common sites of cutaneous involvement are on the skin and head. Extracutaneous involvement is uncommon but reported in the uveal tract, oropharynx, heart, lung, liver, and central nervous Total excision of the tumor is the treatment of choice. It is important to distinguish these tumors from other histiocytic disorders pathologically such as LCH, as they may require more aggressive treatment in contrast to the benign nature of JXG.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest. [6] 14 years/male Paraparesis Cauda equine L2-3 laminectomy with partial excision
Postoperative RT, no recurrence at 2 years Lee et al. 2011 [15] 29 years/male Hemiparesis with contralateral hypothesia below C2 C1-2 C1-2 laminectomy with total excision of tumor Improved Jain et al. 2011 [16] 22 years/female Progressive back pain T7 vertebral body T7 laminectomy with tumor excision
Improved
Agabegi et al. 2011 [12] 47 years/female Bowel, bladder involvement and back pain L2 vertebral body T12-L3 laminectomy with partial excision
Postoperative RT, improved at 8 months Inoue et al. 2011 [7] 38 years/ 
